ג'ייפירקה 50 מ"ג - Jaypirca 50 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | L01EL Bruton's tyrosine kinase (BTK) inhibitors |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Jaypirca as monotherapy is indicated for the treatment of adult patients with relapsed orrefractory mantle cell lymphoma (MCL) who have been previously treated with a Brutonâstyrosine kinase (BTK) inhibitor. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×'××פ××¨×§× 50 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ELI LILLY AND COMPANY, USA |
| ×©× ××¢× ×ר×ש×× | ELI LILLY ISRAEL LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 4/2023. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 28/07/2024 |
השינוי האחרון נעשה בֹ־28 ביולי 2024 ב־13:38